Suspension culture has become the method of choice for the production of a wide range of therapeutic proteins and a number of vaccines. Some recombinant proteins, particularly antibodies, are required in quantities of hundreds of kilograms and even tons per annum. To meet these demands, industrial processes up to 20,000‐L scale have been developed based on stirred reactors, typically operated in batch or fed‐batch mode. For antibodies, optimization of fed‐batch processes has led to very high productivity, and yields of grams per liter are frequently reported. Continuous, perfused systems are also used. Several types of cells are used in these suspension processes, the most common being CHO. It is now possible to grow CHO and other cell types in large‐scale suspension culture using chemically defined media that contain no proteins or animal‐derived materials.